Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors
暂无分享,去创建一个
Y. Matsuno | Y. Ohba | H. Dosaka-akita | T. Shichinohe | T. Itoh | I. Kinoshita | Y. Shimizu | Kayoko Takeda
[1] M. Nishimura,et al. Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant , 2008, British Journal of Cancer.
[2] M. Buendia,et al. Physical and functional cooperation between AP-1 and β-catenin for the regulation of TCF-dependent genes , 2007, Oncogene.
[3] Hans Clevers,et al. Mining the Wnt pathway for cancer therapeutics , 2007, Nature Reviews Drug Discovery.
[4] Axel Behrens,et al. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development , 2005, Nature.
[5] H. McLeod,et al. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. , 2005, American journal of clinical pathology.
[6] J. Sudbø,et al. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients. , 2005, European journal of cancer.
[7] H. Donninger,et al. Cyclin A Is a c-Jun Target Gene and Is Necessary for c-Jun-induced Anchorage-independent Growth in RAT1a Cells* , 2005, Journal of Biological Chemistry.
[8] J. Kench,et al. Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer , 2005, International journal of cancer.
[9] R. Nusse,et al. Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.
[10] J. Chan,et al. Prognostic and Diagnostic Significance of β-Catenin Nuclear Immunostaining in Colorectal Cancer , 2004, Clinical Cancer Research.
[11] S. Roth,et al. Mitogen-activated protein kinases and retinal ischemia. , 2003, Investigative ophthalmology & visual science.
[12] S. C. Wong,et al. Nuclear β catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong , 2003, Molecular pathology : MP.
[13] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[14] M. Birrer,et al. AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets , 2003, Oncogene.
[15] A. Sabichi,et al. Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth , 2003, Oncogene.
[16] Michael Karin,et al. Oncogene at last--c-Jun promotes liver cancer in mice. , 2003, Cancer cell.
[17] E. Wagner,et al. Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.
[18] Y. Shiratori,et al. Analysis of the β‐Catenin/T Cell Factor Signaling Pathway in 36 Gastrointestinal and Liver Cancer Cells , 2002, Japanese journal of cancer research : Gann.
[19] K. Nozaki,et al. Increased Expression of Phosphorylated c-Jun Amino-terminal Kinase and Phosphorylated c-Jun in Human Cerebral Aneurysms: Role of the c-Jun Amino-terminal Kinase/c-Jun Pathway in Apoptosis of Vascular Walls , 2002, Neurosurgery.
[20] M. Pignatelli,et al. β-catenin - A linchpin in colorectal carcinogenesis? , 2002 .
[21] D. Rimm,et al. Tissue Microarray Analysis of β-Catenin in Colorectal Cancer Shows Nuclear Phospho-β-catenin Is Associated with a Better Prognosis , 2001 .
[22] Y. Atomi,et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas , 2001, British Journal of Cancer.
[23] B. Fingleton,et al. The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors , 2001, Molecular and Cellular Biology.
[24] D. Chung,et al. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. , 2000, Gastroenterology.
[25] I. Ellis,et al. Biological and clinical associations of c‐jun activation in human breast cancer , 2000, International journal of cancer.
[26] E. Wagner,et al. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.
[27] L. Sobin,et al. Colon and Rectum , 1998 .
[28] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[29] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[30] S. Steinberg,et al. Altered cJUN expression: an early event in human lung carcinogenesis. , 1996, Cancer research.
[31] M. Birrer,et al. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. , 1994, Oncogene.
[32] J. Woodgett,et al. The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.
[33] M. Karin,et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.
[34] J. Minna,et al. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[36] R. Nusse,et al. Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.
[37] H. Mizuguchi,et al. Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer , 2004, Gene Therapy.
[38] J. Guillem,et al. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] M. Pignatelli,et al. Beta-catenin--a linchpin in colorectal carcinogenesis? , 2002, The American journal of pathology.
[40] D L Rimm,et al. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] Stanley R. Hamilton,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[42] H Clevers,et al. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. , 1999, The American journal of pathology.
[43] F. McCormick,et al. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.
[44] M. Monden,et al. Beta-catenin expression in human cancers. , 1996, The American journal of pathology.